Media store

Media Releases

Published on: 18 June 2019

Japan becomes the first country to approve Roche’s personalised medicine Rozlytrek

Roche today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek® (entrectinib) for the treatment of adult and paediatric patients with neurotrophic tyrosine ...

Published on: 11 June 2019

FDA grants Roche’s Polivy accelerated approval for people with previously treated aggressive lymphoma

Roche today announced that the US Food and Drug Administration (FDA) has granted accelerated approval to Polivy™ (polatuzumab vedotin-piiq) in combination with bendamustine plus Rituxan® (rituximab) ...

Published on: 11 June 2019

Changes in Roche's Board of Directors and Corporate Executive Committee

Roche today announced that Peter Voser (61), a member of the Board of Directors of Roche Holding Ltd since 2011, has decided to step down as a member of the Board of Directors of Roche at the end of ...

Upcoming Events

All

25July

Half year results 2019

(GMT)

Basel

16October

Third quarter sales 2019

(GMT)

Basel

Topics

Media contacts

For media requests

+41 61 688 8888

Media Relations Team

For all general enquiries

Please call the Roche switchboard on
Phone:+41 61 688 11 11